Building upon the existing Accula molecular platform, Mesa’s coronavirus test aims to deliver accurate and accessible testing close to the patient, providing critical information to healthcare providers in China, the United States, and other affected countries
Read MoreWHO calls on industry and governments to increase manufacturing by 40% to meet rising global demand.
Read More
The Bill and Melinda Gates Foundation has granted the partners $885,000 to develop an advanced rapid diagnostic for onchocerciasis.
Read More
The newly developed recombinant antigens derived specifically from COVID-19 are intended for use in infectious disease research, and assay and vaccine development.
Read MoreThe Biomedical Advanced Research and Development Authority will review submissions from organizations seeking to develop molecular diagnostics for 2019-nCoV.
Read More